Healthcare professionals' perspective on the acceptance of gene therapy

Heart Rhythm O2. 2024 Aug 8;5(10):747-749. doi: 10.1016/j.hroo.2024.07.019. eCollection 2024 Oct.

Lian Y Rekker^{1

2}, Erik Renkema³, Femke Hilverda⁴, Linda W van Laake¹, Pieter A Doevendans^{1

5}, Joost P G Sluijter⁶, Pim van der Harst¹, J Peter van Tintelen^{5

7

8}, Anneline S J M Te Riele^{1

5

7}

¹ Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
² Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.
³ Health Services Management and Organisation, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.
⁴ Department of Socio-Medical Sciences, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.
⁵ Netherlands Heart Institute, Utrecht, the Netherlands.
⁶ Laboratory of Experimental Cardiology, Department of Cardiology, UMC Utrecht Regenerative Medicine Center and Circulatory Health Research Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
⁷ Member of the European Reference Network for rare, low prevalence and complex diseases of the heart: ERN GUARD-Heart (ERN GUARDHEART).
⁸ Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

No abstract available